Table 6.
Reference | Group | Characteristics | β | Wald | Exp(β) | 95 % CI | p value |
---|---|---|---|---|---|---|---|
Group 1 (n = 561) | Group 2 (n = 137) | TPU/CrU_0 | 0.62 | 36.82 | 1.86 | 1.52 to 2.28 | <0.001 |
eGFR_0 | −0.05 | 28.07 | 0.95 | 0.94 to 0.97 | <0.001 | ||
Alb_0 | −1.00 | 15.13 | 0.37 | 0.22 to 0.61 | <0.001 | ||
Sex (M) | 0.85 | 11.71 | 2.33 | 1.44 to 3.78 | 0.001 | ||
P_0 | 0.77 | 11.06 | 2.16 | 1.37 to 3.39 | 0.001 | ||
Group 3 (n = 72) | TPU/CrU_0 | 0.89 | 54.67 | 2.43 | 1.92 to 3.08 | <0.001 | |
eGFR_0 | −0.11 | 47.51 | 0.89 | 0.86 to 0.92 | <0.001 | ||
P_0 | 1.74 | 22.91 | 5.70 | 2.79 to 11.62 | <0.001 | ||
Alb_0 | −1.64 | 19.97 | 0.19 | 0.09 to 0.40 | <0.001 | ||
Sex (M) | 1.38 | 12.26 | 3.98 | 1.84 to 8.62 | <0.001 | ||
Group 2 | Group 3 | eGFR_0 | −0.07 | 17.42 | 0.94 | 0.91 to 0.97 | <0.001 |
TPU/CrU_0 | 0.27 | 10.69 | 1.31 | 1.11 to 1.53 | 0.001 | ||
P_0 | 0.97 | 7.59 | 2.64 | 1.32 to 5.27 | 0.006 | ||
Group 1 + 2 | Group 3 | eGFR_0 | −1.00 | 39.42 | 0.91 | 088 to 0.93 | <0.001 |
TPU/CrU_0 | 0.45 | 28.55 | 1.57 | 1.33 to 1.88 | <0.001 | ||
Alb_0 | −1.31 | 15.03 | 0.27 | 0.14 to 0.52 | <0.001 | ||
P_0 | 1.23 | 12.79 | 3.44 | 1.75 to 6.76 | <0.001 | ||
Age | −0.31 | 6.29 | 0.97 | 0.95 to 0.99 | 0.012 | ||
Sex (M) | 0.85 | 5.23 | 2.35 | 1.13 to 4.88 | 0.022 |
Groups 1, 2, and 3 correspond to % decline of eGFR per year <10 %, 10–25 %, and >25 %, respectively
Independent variables included age, sex, eGFR_0, DMN, BMI_0, SBP_0, Hb_0, Alb_0, UA_0, Na_0, K_0, Na-Cl_0, cCa_0, P_0, CRP_0, LDL-C_0, TPU/CrU_0, UB_score_0, RASi_0